According to the CEO and Chairman of pharmaceutical giant Eli
Lilly, the biomedical breakthroughs that are occurring within the
industry are transforming medicine and promise to ease the
challenges facing an aging population.
GlaxoSmithKline (GSK) has formed a partnership with ChemoCentryx
worth $1.5bn (€1.2bn) which will provide the company with access to
selected targets from one of the broadest pipelines of
chemokine-based therapeutics in the biotech...
Evotec and CHDI have formed a strategic partnership, which aims to
research and develop treatments for Huntington Disease (HD), a
genetic disorder that causes programmed degeneration of brain cells
and loss of intellectual faculties.
Charles River Laboratories becomes the ninth contract research
organisation (CRO) to open up a new pathology facility within the
Chicago Technology Park (CTP), reinforcing the emerging outsourcing
trend in pharmaceutical discovery...
Global drug development spending will top $105bn (€81.5bn) by 2010
and 40 per cent of this business is expected to be dished out in
outsourcing contracts - with contract research organisations (CROs)
emerging triumphant.
Covance, the world's largest provider of drug-development services,
is bracing itself for the onslaught of protests by animal rights
activists who are demonstrating against the building of a $100m
(€78.6) laboratory in the US.
A new service introduced on the back of customer demand has been
launched by Aviva Systems Biology which make available a method for
genome-wide detection of promoters and enhancers that interact with
proteins or carry modifications.
GlaxoSmithKline (GSK) has decided to outsource its research in
genotyping by awarding a contract to Expression Analysis who will
provide the pharma giants with microarray-based genotyping
services.
Aldevron has announced the expansion of its Genetic Immunisation
and Antibody (GIA) facility to meet the increased demand of vaccine
screening contracts.
Despite looming threats from cheap Asian competitors, European
contract research organisations (CROs) still have a fighting chance
in the global R&D outsourcing market, according to a report by
research analysts Frost & Sullivan.
Wyeth has announced that it has selected NovaScreen to conduct a
high-throughput screening (HTS) campaign, which makes use of
Caliper's microfluidic screening platform, which utilises
reproducible electrophoretic separation of...
As clinical trial activity in the Asia Pacific region continues to
boom, Novotech, the largest Australian owned contract research
organisation (CRO) has presented a checklist to help pharma firms
minimise risk when choosing a partner.
As financial pressures continue to plague the pharma industry,
firms should consider taking more advantage of sourcing staff in
cheap labour markets in order to save a buck.
China could be the first country to conduct human stem cell trials
and presents a significant opportunity for Western companies who
are brave enough to use this risky destination as a place to pursue
this potentially lucrative sector...
Covance has stepped up its laboratory testing capabilities in the
Asia Pacific region to satisfy the growing number of sponsors
conducting clinical studies in this budding location.
China-based Natural Pharmatech has formed its first research
contract with a Japanese company, Kobayashi Pharmaceutical -
another step forward in Natural Pharmatech's plans to bring its
botanical R&D services to the global...
Discovery Partners International is offloading its unprofitable
contract drug discovery operations and merging with Infinity
Pharmaceuticals to create a new public company focused on cancer
drug discovery and development.
As China improves its resources and regulatory processes it will
soon become a hotbed of clinical drug research activity, and
position itself as one of the world's most important countries in
this field, according to a new report...
As contract research organisations (CROs) continue to search for
cost-effective countries in which to operate, the clinical trials
market is increasingly expanding into emerging economies. Central
and Eastern Europe are continuing...
Drug companies are leaning more heavily on contract research
organisations (CROs) to save costs in getting new drugs to market.
And it is paying off, with added benefits. Companies who rely on
CROs are also completing clinical trials...
UK's Pharmagene has joined forces with US company Asterand to form
a human tissue supply and research services company that will
dominate the pharma industry. The merger, which was finalised last
week, will also solidify Pharmagene's...
The use of internal standards (IS) is essential for developing and applying liquid chromatography-tandem mass spectrometric (LC-MS/MS) quantitative bioanalytical...
Global regulatory standards govern bioanalytical method development, validation and the subsequent assays. When those standards are updated, industry stakeholders...
Understanding pharmacokinetic behaviors ahead of later-stage development means making informed decisions earlier. This enhanced capability helps your drug...
